Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxin Qiwei dropping pill versus compound danshen dropping pill for stable angina of coronary heart disease
ChiCTR-IPR-15006605Phase 4Completed
- Sponsor
- First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Guanxin Qiwei dropping pill and Compound Danshen in coronary arteriosclerosis and stable angina (2 arms), sponsored by First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine. Primary endpoint: Angina symptoms. Started Apr 2011; status: completed.
02
Drugs
Guanxin Qiwei dropping pillCompound Danshen
03
Conditions
coronary arteriosclerosisstable angina
Beyond the preview
Go deeper on ChiCTR-IPR-15006605.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15006605.